Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2023

Sep 14, 2023

3535_rns_2023-09-14_8a1e7f39-bf6e-42ee-bd8c-b17b8bbfb61c.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA -NEW SHARE CAPITAL REGISTERED

AQUA BIO TECHNOLOGY ASA -NEW SHARE CAPITAL REGISTERED

14.9.2023 10:42:49 CEST | Aqua Bio Technology ASA | Total number of voting

rights and capital

Reference is made to the stock exchange announcement from Aqua Bio Technology

ASA ("ABTEC" or the "Company") on 24 August 2023 regarding the extraordinary

general meeting resolving, among other things, to issue 15,400,383 consideration

shares to the sellers' of Skinteam Norge AS and certain investors, and 9,457,686

private placement shares to certain investors and existing shareholders

(jointly, the "New Shares").

The share capital increases pertaining to the issuance of the New Shares has

today been registered with the Norwegian Registry of Business Enterprises (Nw.

Foretaksregisteret). ABTEC's s new share capital is NOK 118,540,742.50 divided

into 47,416,297 shares, each with a nominal value of NOK 2.5.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

* * *

Aqua Bio Technology (ABTEC) is developing and commercializing sustainable

biotechnology for use in skin care products. ABTEC's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABTEC is also marketing and

distributing natural skin care products developed by partners towards consumers

and professional users. ABTEC's focus on commercialization and development of

natural ingredients and natural skin care products has been, and will continue

to be, an important part of the Company's strategy going forward. ABTEC is

listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2617/3661/Download%20announcement

%20as%20PDF.pdf